The application of Gene Set Variation Analysis (GSVA) enabled us to quantify the collective expression of these NMUR1-correlated genes, revealing that higher GSVA scores were indicative of a decreased mortality risk (Figure S6D) and were associated with earlier pathologic stages of COAD (Figure S6E). This evidence concerns the gene NMUR1 and colon adenocarcinoma.